Pharmacovigilance Agreement Management

ADRium™ Agreements is a tool within our ADRium™ PV suite and PVaaS cloud-based platform designed to streamline the management of Pharmacovigilance Agreements (PVAs) for biopharmaceutical companies. This tool simplifies complex PVA processes, ensuring compliance and enhancing efficiency through user-friendly features and robust support.

Streamline PVA management with a dedicated tool

ADRium™ Agreements showcases how effective management of PVAs can enhance regulatory workflows. Our platform enables clients to efficiently handle the entire agreement lifecycle, from drafting and tracking to compliance reporting. The examples below reveal how ADRium™ Agreements improves agreement handling and adherence.

Streamline PVA creation and partner integration

  • Utilize in-built templates with dynamic content to draft agreements and efficiently capture local PV requirements
  • Manage partner information and track PVA statuses seamlessly
  • Facilitate faster contract processing and approval through integrated workflows

Enhance contract processing

  • Oversee drafts, reviews, and negotiations with a unified system
  • Securely finalize agreements using digital signatures or DocuSign for compliant, efficient processing

Enhance data exchange and visibility

  • Connect with PV safety databases to automate adverse event reporting and reconcile data monthly
  • Generate detailed reports and dashboards for PVA metrics, partner lists, and product information, with notifications for periodic reviews

Ensure secure access and detailed auditing

  • Implement access controls to safeguard sensitive information
  • Maintain a detailed audit trail for transparency and regulatory compliance

why synapmed?

Synapmed’s ADRium™ Agreements provides a comprehensive, cloud-based solution for managing Pharmacovigilance Agreements (PVAs). Our PVaaS platform combines advanced technology with expert support to streamline PVA creation, enhance partner management, and ensure compliance. With dynamic templates, secure digital processing, and robust data integration, Synapmed improves workflow efficiency and data accuracy. Our commitment to security and real-time reporting helps you focus on bringing safe, effective products to market.

Frequently asked questions

What are Pharmacovigilance Agreements (PVAs)?
Pharmacovigilance Agreements (PVAs) are contracts between parties involved in drug development and distribution. They outline how adverse drug events will be monitored and reported to ensure safety and compliance with regulations.
PVAs are crucial for ensuring that all parties involved in drug development and distribution adhere to safety regulations. They help ensure that adverse events are reported accurately and promptly, which is essential for maintaining drug safety and regulatory compliance.
Managing PVAs can be simplified by using tools that provide templates for drafting agreements, track agreement status, and facilitate digital signatures. These tools help streamline the agreement process, making it more efficient and ensuring compliance with regulatory requirements.
A good PVA management tool should have features like easy-to-use templates, tracking and reporting capabilities, secure digital processing, and integration with safety databases. These features help manage the agreement lifecycle more effectively.

Ensuring data security involves using tools that offer strong access controls, encryption, and detailed audit trails. These measures protect sensitive information and help maintain compliance with data protection regulations.

ADRium™ Agreements is a cloud-based tool designed to manage Pharmacovigilance Agreements (PVAs). It helps streamline the PVA process with features like customizable templates, digital signatures, and integration with safety databases, making it easier to draft, track, and report on PVAs while ensuring compliance and data security.
outsourcing

Pharmacovigilance — Should You Outsource?

Navigating pharmacovigilance presents substantial challenges for life sciences companies, especially when interpreting the finer points of compliance. Failure to meet these stringent requirements can lead to severe consequences, including inspections or even revocation of marketing authorization. Companies face a critical decision: should they manage pharmacovigilance operations in-house or outsource to specialized firms? Each option has its own set of advantages and drawbacks, and understanding these is key to maintaining compliance and ensuring the safety of products on the market.

Dedicated to youR Project

No matter the size or scope of your projects, you have a committed partnership team with Synapmed. We’re a team that listens, pays attention to details, and brings smart insights to the table. We do it all so you can solve real problems throughout the product development and commercialization lifecycle.